Valuation: LigaChem Biosciences Inc.

Capitalization 6,917B 4.66B 4.03B 3.65B 3.5B 6.38B 428B 6.67B 43.13B 17.24B 205B 17.47B 17.1B 734B P/E ratio 2025 *
-439x
P/E ratio 2026 * 576x
Enterprise value 6.3B 4.24M 3.67M 3.32M 3.19M 5.81M 389M 6.07M 39.28M 15.69M 187M 15.91M 15.57M 669M EV / Sales 2025
44.7x
EV / Sales 2026 * 22.5x
Free-Float
69.99%
Yield 2025 *
-
Yield 2026 * -
26/01 1ST Biotherapeutics, Inc. announced that it has received KRW 31.7 billion in funding from a group of investors CI
23/01 Nextcure, Inc. Provides Updates for Its Two Antibody Drug Conjugate Programs CI
14/11 LigaChem Biosciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
01/10/25 Ligachem Biosciences to divest 5 billion won worth of own shares RE
14/08/25 LigaChem Biosciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
27/06/25 Tranche Update on LigaChem Biosciences Inc.'s Equity Buyback Plan announced on March 25, 2025. CI
30/05/25 NextCure and LigaChemBio to Present Trial in Progress Poster for LNCB74, a B7-H4 Targeted Antibody-Drug Conjugate, as Monotherapy in Participants with Advanced Solid Tumors at ASCO 2025 CI
15/05/25 LigaChem Biosciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
08/04/25 Ligachem Biosciences To Divest 17 Billion Won Worth Of Own Shares RE
08/04/25 Tranche Update on LigaChem Biosciences Inc.'s Equity Buyback Plan announced on October 14, 2024. CI
08/04/25 Tranche Update on LigaChem Biosciences Inc.'s Equity Buyback Plan announced on October 14, 2024. CI
08/04/25 LegoChem Biosciences, Inc.'s Equity Buyback announced on October 14, 2024, has expired with of 188,321 shares, representing 0.52% for KRW 19,956.38 million. CI
25/03/25 LigaChem Biosciences Inc. announces an Equity Buyback for KRW 7,000 million worth of its shares. CI
1 day+17.36%
1 week+1.44%
Current month-0.89%
1 month+4.40%
3 months+2.43%
6 months+24.92%
Current year+9.38%
1 week 159,900
Extreme 159900
209,000
1 month 159,900
Extreme 159900
209,000
Current year 141,600
Extreme 141600
221,500
1 year 89,500
Extreme 89500
221,500
3 years 31,200
Extreme 31200
221,500
5 years 30,050
Extreme 30050
221,500
10 years 11,525
Extreme 11525
221,500
Manager TitleAgeSince
Chief Executive Officer 69 15/09/2011
Director of Finance/CFO 64 15/09/2011
Director TitleAgeSince
Director/Board Member 69 02/05/2006
Director/Board Member 64 01/07/2007
Director/Board Member 66 -
Change 5d. change 1-year change 3-years change Capi.($)
+17.36%+1.44%+64.36%+410.07% 4.03B
-2.55%-3.99%+5.71%+92.32% 45.72B
+0.47%-5.67%+54.34%+11.05% 39.82B
-4.21%-4.29%+85.13%+596.94% 32.31B
-1.78%-6.30%-11.17%-22.04% 26.05B
+0.73%-11.29%+51.51%-37.68% 18.68B
-1.03%-3.24%+7.28%-30.72% 17.17B
-2.86%-5.44%-23.58%+870.13% 11.93B
+3.33%-1.87%+45.90%+141.43% 11.23B
-0.98%-6.78%+6.80%+140.70% 10.83B
Average +0.79%-5.66%+28.63%+217.22% 21.78B
Weighted average by Cap. -1.05%-5.70%+30.03%+171.21%

Financials

2025 2026 *
Net sales 161B 109M 93.92M 85.05M 81.65M 149M 9.97B 155M 1.01B 402M 4.78B 408M 399M 17.13B 284B 191M 165M 150M 144M 262M 17.55B 274M 1.77B 707M 8.41B 717M 702M 30.14B
Net income -16.01B -10.78M -9.32M -8.44M -8.1M -14.78M -990M -15.43M -99.86M -39.9M -474M -40.45M -39.59M -1.7B 11.78B 7.93M 6.86M 6.21M 5.96M 10.87M 728M 11.35M 73.47M 29.36M 349M 29.76M 29.13M 1.25B
Net Debt -618B -416M -360M -326M -313M -571M -38.21B -596M -3.86B -1.54B -18.31B -1.56B -1.53B -65.65B -521B -351M -303M -275M -264M -481M -32.21B -502M -3.25B -1.3B -15.43B -1.32B -1.29B -55.33B
Logo LigaChem Biosciences Inc.
LigaChem Biosciences Inc, formerly LegoChem Biosciences Inc, is a Korea-based company mainly engaged in development and discovery of new pharmaceuticals based on medical chemistry. The Company principally involves in the development of new drugs, including antibiotics, anticoagulants, anticancer, antiplatelet, anti-inflammatory, as well as antibody-drug-conjugates (ADC), among others. The Company provides technology transfer, joint and contact research and research services. In addition, the Company sells medical devices, medical supplies, prescription drugs, and over the counter (OTC) drugs.
Employees
170
Date Price Change Volume
05/03/26 190,000.00 +17.36% 606,243
04/03/26 161,900.00 -15.81% 546,405
03/03/26 192,300.00 +0.31% 711,159
27/02/26 191,700.00 +2.35% 360,988
26/02/26 187,300.00 +1.57% 400,993
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
190,000.00KRW
Average target price
215,000.00KRW
Spread / Average Target
+13.16%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A141080 Stock